ArticleJournal of translational medicine2023

Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways.

Arshi Khanam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.